Center-Authored Papers

Filters: Author is Chamberlain, Marc C  [Clear All Filters]
A
B
C
Chamberlain MC.  2008.  Bevacizumab plus irinotecan in recurrent glioblastoma.. Journal of clinical oncology : official journal of the American Society of Clinical Oncology. 26(6):1012-3;authorreply1013.
Chamberlain MC.  2011.  How fine a slice: treatment of newly diagnosed glioblastoma with an epidermal growth factor receptor variant III peptide vaccine.. Journal of clinical oncology : official journal of the American Society of Clinical Oncology. 29(17):e517-8;authorreplye519-20.
Chamberlain MC, Goulart BHL.  2013.  Are prognostic factors for leptomeningeal metastases defined sufficiently to permit tailored treatment? Journal of thoracic oncology : official publication of the International Association for the Study of Lung Cancer. 8(7):e66-7.
Chamberlain MC.  2014.  Lessons Learned From Radiation Therapy Oncology Group 0525 Trial.. Journal of clinical oncology : official journal of the American Society of Clinical Oncology.
Chamberlain MC.  2016.  What Lessons Are Imparted From SWOG S9005 for Recurrent Meningioma? Journal of clinical oncology : official journal of the American Society of Clinical Oncology.
Chamberlain MC, Eaton K.  2012.  Is there a role for whole brain radiotherapy in the treatment of leptomeningeal metastases? Journal of thoracic oncology : official publication of the International Association for the Study of Lung Cancer. 7(7):1204;authorreply1204-5.
Chamberlain MC.  2008.  Pseudoprogression in glioblastoma.. Journal of clinical oncology : official journal of the American Society of Clinical Oncology. 26(26):4359;authorreply4359-60.
Chamberlain MC.  2013.  Should erlotinib be coadministered with whole-brain radiotherapy in patients with brain metastases and non-small-cell lung cancer? Journal of clinical oncology : official journal of the American Society of Clinical Oncology. 31(25):3164-5.